Methods for manufacturing contact lenses are provided. In an embodiment, the method includes mixing a siloxane macromer represented by the following formula (I), a hydrophilic monomer, a crosslinking agent or a siloxane macromer represented by the following formula (II), and an initiator to form a mixture. Then the mixture is injected into a mold of contact lens and heated to form contact lenses. The formula (I) and the formula (II) are shown respectively as the following:

##STR00001##
wherein R1, R2 and R3 are independently C1-C4 alkyl groups, R4 is C1-C6 alkyl group, R5 is a residue obtained by removing nco group from an aliphatic or aromatic diisocyanate, R6 and R7 are independently alkylene groups, and n is an integer of 4-80, m is an integer of 3-40.

##STR00002##
wherein p is an integer of 4-80 and q is an integer of 3-40.

Patent
   10101501
Priority
Sep 02 2011
Filed
Oct 19 2016
Issued
Oct 16 2018
Expiry
Aug 09 2032

TERM.DISCL.
Extension
66 days
Assg.orig
Entity
Large
0
4
currently ok
1. A method for manufacturing contact lenses comprising:
(a) mixing a siloxane macromer represented by the following formula (I), a hydrophilic monomer, a crosslinking agent and an initiator to form a mixture; and
(b) injecting the mixture into a mold of contact lens and heating the mixture to form contact lenses;
wherein the molecular weight of the siloxane macromer of formula (I) is 1,000 to 10,000:
##STR00013##
wherein R1, R2 and R3 are independently C1-C4 alkyl groups, R4 is C1-C6 alkyl group, R5 is a residue obtained by removing nco group from an aliphatic or aromatic diisocyanate, R6 and R7 are independently alkylene groups, and n is an integer of 4-80, m is an integer of 3-40;
moreover, the hydrophilic monomer is selected from a group consisting of 2-hydroxyethyl methacrylate (HEMA), N-vinylpyrrolidone (NVP), methyl acrylic acid, acrylic acid, glycidyl methacrylate, (methyl)acrylamide, N,N-dimethylacrylamide, vinyl bamate and a combination of said materials thereof.
2. The method for manufacturing contact lenses according to claim 1, wherein the hydrophilic monomers is a combination of HEMA and NVP.
3. The method for manufacturing contact lenses according to claim 1, wherein the crosslinking agent is selected from a group consisting of ethylene glycol dimethacrylate (EGDMA), tetraethylene ethylene glycol dimethacrylate (TEGDMA), tetraethylene ethylene glycol dimethacrylate (TrEGDMA), poly(ethylene glycol) dimethacrylate, trimethylolpropane trimethacrylate, vinyl methacrylate, ethylenediamine dimethyl acrylamide, glycerol dimethacrylate, triallyisoeyanurate and triallyl cyanurate.
4. The method for manufacturing contact lenses according to claim 1, wherein the initiator is selected from a group consisting of azobisisoheptonitrile (ADVN), 2,2′azobis(isoheptonitrile) (AIBN), 2,2′-azobis(2,4-dimethylvaleronitrile), 2,2′-azobis(2-methyl-propanenitrile), 2,2′-azobis(2-methyl-butanenitrile) and benzoyl peroxide.
5. The method for manufacturing contact lenses according to claim 1, wherein the siloxane macromer of formula (I) is present at an amount of 30 to 40 parts by weight, the hydrophilic monomer is present at an amount of 40 to 65 parts by weight, the crosslinking agent is present at an amount of 1 to 10 parts by weight and the initiator is present at an amount of 0.1 to 1 parts by weight based on the total amount of the mixture.
6. The method for manufacturing contact lenses according to claim 5, wherein the hydrophilic monomer is a combination of HEMA and NW, wherein the HEMA is present at an amount of 1 to 20 parts by weight and the NVP is present at an amount of 40 to 55 parts by weight based on the total amount of the mixture.
7. The method for manufacturing contact lenses according to claim 1, wherein the siloxane macromer of formula (I) comprising a siloxane macromer represented by the following formula (III):
##STR00014##
wherein r is an integer of 4-80 and s is an integer of 3-40.

The present application is a divisional of the application Ser. No. 14/726,592 filed on May 31, 2015, now U.S. Pat. No. 9,527,251, which is a divisional of the application Ser. No. 13/488,420 filed on Jun. 4, 2012, now U.S. Pat. No. 9,523,793, and claims priority under 35 U.S.C. 119(e) to Taiwanese application serial number 100131653 filed on Sep. 2, 2011 the entire contents of which are hereby incorporated herein by reference.

The present invention relates to a composition for manufacturing contact lenses. More particularly, the present invention relates to a composition for manufacturing contact lenses comprising hydrophilic siloxane macromer.

The hydrogel contact lenses are made from hydrogel materials, such as poly-2-hydroxyethyl methacrylate (p-HEMA), and the strength of 2-hydroxyethyl methacrylate (HEMA) can be improved by adding crosslinking agent like ethylene glycol dimethacryate (EGDMA). Since the water content of the HEMA is only about 38.8% the hydrophilic monomer, for example N-vinylpyrrolidone, N,N-dimethylacrylamide and methyl acrylic acid, is added to improve the water content of such materials for the contact lenses. With the addition of the hydrophilic monomer, the water content of the contact lenses can increase up to 80%. However, the higher water content of the contact lenses is, the lower tension and toughness thereof become. The water content of contact lenses generally ranges from about 45% to 58%, but the real oxygen permeability can only reach about 15-35 regardless the further improvement of the water content.

Silicone hydrogel contact lenses have better oxygen permeability than hydrogel contact lenses. Silicone hydrogel contact lenses comprises a silicone polymeric material which was made by polymerizing two siloxane macromers, which have different chemical structures and different molecular weights, and a hydrophilic monomer, such as N-vinylpyrrolidone (NVP), methyl acrylic acid and N,N-dimethylacrylamide.

However, because of the hydrophobic characteristic on the surface of silicone hydrogel contact lenses, it is apt to incur the bacteria breed and eyes irritation. Therefore, an object of the present invention is to provide a composition of contact lenses and a method for manufacturing contact lenses by using the same to surmount the aforesaid disadvantages of the prior art.

According to an aspect of the present invention, a composition for manufacturing contact lenses is provided.

In an embodiment of the present invention, the composition for manufacturing contact lenses comprises a siloxane macromer represented by the following formula (I), a hydrophilic monomer, a crosslinking agent and an initiator. The formula (I) is

##STR00003##
wherein R1, R2 and R3 are independently C1-C4 alkyl groups, R4 is C1-C6 alkyl group, R5 is a residue obtained by removing NCO group from an aliphatic or aromatic diisocyanate, R6 and R7 are independently alkylene groups, and n is an integer of 4-80, m is an integer of 3-40, and the molecular weight of the siloxane macromer of formula (I) is 1,000 to 10,000.

In an embodiment of the present composition for manufacturing contact lenses, the hydrophilic monomer is selected from a group consisting of 2-hydroxyethyl methacrylate (HEMA), N-vinylpyrrolidone (NVP), methyl acrylic acid, acrylic acid, glycidyl methacrylate, (methyl) acrylamide, N,N-dimethylacrylamide, vinyl bamate and a combination thereof.

In another embodiment of the present composition for manufacturing contact lenses, the composition for manufacturing contact lenses comprises a siloxane macromer of formula (I) defined as above, a hydrophilic monomer a siloxane macromer represented by the following formula (II) and an initiator. The formula (II) is

##STR00004##
wherein p an integer of 4-80 and q is an integer of 3-40.

According to a further aspect of the present invention, the composition for manufacturing contact lenses comprises a siloxane macromer of formula (I) defined as above a hydrophilic monomer, a siloxane macromer of formula (II) defined as above, a crosslinking agent and an initiator.

According to a further another aspect of the present invention, a method for manufacturing the contact lenses is provided.

In an embodiment of the method of the present invention, the method for manufacturing the contact lenses comprises the following steps. First, a siloxane macromer of formula (I) defined as above, a hydrophilic monomer, a crosslinking agent and an initiator are mixed to form a mixture. Then, the mixture is injected into a mold of contact lens and heated to form contact lenses.

In another embodiment of the method of the present invention, the method for manufacturing the contact lenses comprises the following steps. First, siloxane macromer of formula (I) defined as above, a hydrophilic monomer, a siloxane macromer of formula (II) defined as above and an initiator are mixed to form a mixture. Then, the mixture is injected into a mold of contact lens and heated to form contact lenses.

In still another embodiment of the method of the present invention, the method for manufacturing the contact lenses comprises the following steps. First, a siloxane macromer of formula (I) defined as above, a hydrophilic monomer, a siloxane macromer of formula (II) defined as above, a crosslinking agent and an initiator are mixed to form a mixture. Then, the mixture is injected into a mold of contact lens and heated to form contact lenses.

The above and other aspects of the invention will become better understood with regard to the following detailed description of the preferred but nonlimiting embodiment(s).

Accordingly, a composition for manufacturing contact lenses and a method for manufacturing contact lenses by using the same are provided. In the following detailed description, for purposes of explanation, numerous specific details are set forth in order to provide a thorough understanding of the disclosed embodiments. It will be apparent, however, that one or more embodiments may be practiced without these specific details.

According to an aspect of the present invention, a composition for manufacturing contact lenses is provided. The contact lenses have hydrophilic surface, excellent oxygen permeability and high water content.

In an embodiment of the present invention, the composition for manufacturing contact lenses comprises a siloxane macromer represented by the following formula (I), a hydrophilic monomer, an initiator and a crosslinking agent or a siloxane macromer represented by the following formula (II), wherein the formula (I) is

##STR00005##
wherein R1, R2 and R3 are independently C1-C4 alkyl groups, R4 is C1-C6 alkyl group, R5 is a residue obtained by removing NCO group from an aliphatic or aromatic diisocyanate, R6 and R7 are independently alkylene groups, and n is an integer of 4-80, m is an integer of 3-40 and the molecular weight of the siloxane macromer of formula (I) is 1,000 to 10,000.

And the formula (II) is

##STR00006##
wherein p is an integer of 4-80, q is an integer of 3-40.

The hydrophilic monomer is selected from a group consisting of 2-hydroxyethyl methacrylate (HEMA), N-vinylpyrrolidone (NVP), methyl acrylic acid, acrylic acid, glycidyl methacrylate, (methyl) acrylamide, N,N-dimethylacrylamide, vinyl bamate and a combination thereof. In an embodiment of composition for manufacturing contact lenses of the present invention, the hydrophilic monomer is a combination of HEMA and NVP.

In addition, the siloxane macromer of formula (II) defined as above provides a crosslinking function. In an embodiment of composition for manufacturing contact lenses of the present invention, the present composition comprises one of the siloxane macromer of formula (II) and a crosslinking agent. In another embodiment of composition for manufacturing contact lenses of the present invention, the present composition for manufacturing contact lenses comprises both the siloxane macromer of formula (II) and a crosslinking agent.

In an embodiment of composition for manufacturing contact lenses of the present invention, the siloxane macromer of formula (I) comprises but not limited to a siloxane macromer represented by the following formula (III):

##STR00007##
wherein r is an integer of 4-80 and s is an integer of 3-40.

Moreover, the crosslinking agent suitably used in conventional compositions for manufacturing contact lenses can be used in the composition of the present invention, such as, for example, ethylene glycol dimethacrylate (EGDMA), tetraethylene ethylene glycol dimethacrylate (TEGDMA), tetraethylene ethylene glycol dimethacrylate (TrEGDMA), Poly(ethylene glycol) dimethacrylate, trimethylolpropane trimethacrylate, vinyl methacrylate, ethylenediamine dimethyl acrylamide, glycerol dimethacrylate, triallyisocyanurate or triallyl cyanurate. In a preferred embodiment of composition for manufacturing contact lenses of the present invention, the crosslinking agent is EGDMA.

The initiator suitably used in conventional compositions for manufacturing contact lenses can be used in the composition of the present invention, such as, for example, azobisisoheptonitrile (ADVN), 2,2′-azobis(isoheptonitrile) (AIBN), 2,2′-azobis(2,4-dimethylvaleronitrile), 2,2′-azobis(2-methyl-propanenitrile), 2,2′-azobis(2-methyl-butanenitrile) or benzoyl peroxide. In a preferred embodiment of composition for manufacturing contact lenses of the present invention, the initiator is ADVN.

In an embodiment of composition for manufacturing contact lenses of the present invention, the composition of contact lenses comprises a siloxane macromer of formula (I) defined as above, a hydrophilic monomer, a crosslinking agent and an initiator. In the composition of this embodiment, the siloxane macromer of formula (I) is present at an amount of 30 to 40 parts by weight, the hydrophilic monomer is present at an amount of 40 to 65 parts by weight, the crosslinking agent is present at an amount of 1 to 10 parts by weight and the initiator is present at an amount of 0.1 to 1 parts by weight based on the total amount of the composition. Furthermore, the hydrophilic monomer used in this embodiment is a combination of HEMA and NVP, wherein the HEMA is present at an amount of 1 to 5 parts by weight and the NVP is present at an amount of 40 to 60 parts by weight based on the total amount of the composition.

In another embodiment of composition for manufacturing contact lenses of the present invention, the composition for manufacturing contact lenses comprises a siloxane macromer of formula (I) defined as above a hydrophilic monomer, a crosslinking agent, an initiator and a siloxane macromer of formula (II) defined as above. In this embodiment, the siloxane macromer of formula (I) is present at an amount of 20 to 45 parts by weight, the hydrophilic monomer is present at an amount of 40 to 75 parts by weight, the crosslinking agent is present at an amount of 1 to 5 parts by weight, the siloxane macromer of formula (II) is present at an amount of 5 to 20 parts by weight and the initiator is present at an amount of 0.1 to 1 parts by weight based on the total amount of the composition. Furthermore, the hydrophilic monomer used in this embodiment is a combination of HEMA and NVP, wherein the HEMA is present at an amount of 1 to 20 parts by weight and the NW is present at an amount of 40 to 55 parts by weight based on the total amount of the composition.

According to another aspect of the present invention, a composition for manufacturing contact lenses is provided. The contact lenses have hydrophilic surface, excellent oxygen permeability and high water content.

In an embodiment of composition for manufacturing contact lenses of the present invention, the composition of contact lenses comprises a siloxane macromer of formula (I) defined as above, a hydrophilic monomer, an initiator and a siloxane macromer of formula (II) defined as above. In the composition of this embodiment the siloxane macromer of formula is present at an amount of 15 to 45 parts by weight, the hydrophilic monomer is present at an amount of 40 to 75 parts by weight, the siloxane macromer of formula (II) is present at an amount of 5 to 30 parts by weight and the initiator is present at an amount of 0.1 to 1 parts by weight based on the total amount of the composition. Furthermore, the hydrophilic monomer used in this embodiment is a combination of HEMA and NVP, wherein the HEMA is present at an amount of 1 to 15 parts by weight and the NVP is present at an amount of 40 to 60 parts by weight based on the total amount of the composition.

In addition, the composition for manufacturing contact lenses can further comprise but not limited to a dye and an anti-UV agent.

According to a further aspect of the present invention, a method for manufacturing contact lenses is provided. The contact lenses made by the present method have hydrophilic surface, excellent oxygen permeability and high water content. The method can comprise but not limited to the following steps.

First, a siloxane macromer represented by the following formula (I), a hydrophilic monomer, an initiator and a crossling agent or a siloxane macromer represented by the following formula (II) are mixed to form a mixture. Then, the mixture is injecting into a mold of contact lens and heating the mixture to form contact lenses. The molecular weight of the siloxane macromer of formula (I) is 1,000 to 10,000. The formula (I) is

##STR00008##
wherein R1, R2 and R3 are independently C1-C4 alkyl groups, R4 is C1-C6 alkyl group, R5 is a residue obtained by removing NCO group from an aliphatic or aromatic diisocyanate, R6 and R7 are independently alkylene groups, and n is an integer of 4-80, m is an integer of 3-40;
and the formula (II) is

##STR00009##
wherein p is an integer of 4-80 and q is an integer of 3-40,

The hydrophilic monomer is selected from a group consisting of 2-hydroxyethyl methacrylate (HEMA), N-vinylpyrrolidone (NVP), methyl acrylic acid, acrylic acid, glycidyl methacrylate, (methyl)acrylamide, N,N-dimethylacrylamide, vinyl bamate and a combination of said materials thereof. In an embodiment of the method of the present invention, the hydrophilic monomer is a combination of HEMA and NVP.

In addition, the siloxane macromer of formula (II) provides a crosslinking function. In an embodiment of the method of the present invention, the mixture comprises one of the siloxane macromer of formula (II) and crosslinking agent. In another embodiment of the method of the present invention, the mixture comprises both the siloxane macromer of formula (II) and crosslinking agent.

In an embodiment of the method of the present invention, the siloxane macromer of formula (I) comprises but not limited to a siloxane macromer represented by the following formula (III):

##STR00010##
wherein r is an integer of 4-80 and s is an integer of 3-40.

Moreover, the crosslinking agent suitably used in conventional compositions for manufacturing contact lenses can be used in the method of the present invention, such as, for example, ethylene glycol dimethacrylate (EGDMA), tetraethylene ethylene glycol dimethacrylate (TEGDMA), tetraethylene ethylene glycol dimethacrylate (TrEGDMA), Poly(ethylene glycol) dimethacrylate, trimethylolpropane trimethacrylate, vinyl methacrylate, ethylenediamine dimethyl acrylamide, glycerol dimethacrylate, triallyisocyanurate or triallyl cyanurate. In a preferred embodiment of the method of the present invention, the crosslinking agent is ethylene glycol dimethacrylate (EGDMA).

Besides, the initiator suitably used in conventional compositions for manufacturing contact lenses can be used in the method of the present invention, such as, for example, azobisisoheptonitrile (ADVN), 2,2′-azobis(isoheptonitrile) (AIBN), 2,2′-azobis(2,4-dimethylvaleronitrile), 2,2′-azobis(2-methyl-propanenitrile), 2,2′-azobis(2-methyl-butanenitrile) or benzoyl peroxide. In a preferred embodiment of the method of the present invention, the initiator is ADVN.

In an embodiment of the method of the present invention, the step of forming the mixture comprises mixing a siloxane macromer of formula (I) defined as above, a hydrophilic monomer, a crosslinking agent and an initiator to form a mixture. In the method of this embodiment, the siloxane macromer of formula (I) is present at an amount of 30 to 40 parts by weight, the hydrophilic monomer is present at an amount of 40 to 65 parts by weight, the crosslinking agent is present at an amount of 1 to 10 parts by weight and the initiator is present at an amount of 0.1 to 1 parts by weight based on the total amount of the mixture. Furthermore, the hydrophilic monomer used in this embodiment is a combination of HEMA and NVP, wherein the HEMA is present at an amount of 1 to 5 parts by weight and the NVP is present at an amount of 40 to 60 parts by weight based on the total amount of the mixture.

In another embodiment of the method of the present invention, the step of forming the mixture further comprises mixing a siloxane macromer of formula (I) defined as above, a hydrophilic monomer, a crosslinking agent, an initiator and a siloxane macromer of formula (II) defined as above to form the mixture. In the method of this embodiment, the siloxane macromer of formula (I) is present at an amount of 20 to 45 parts by weight, the hydrophilic monomer is present at an amount of 40 to 75 parts by weight, the crosslinking agent is present at an amount of 1 to 5 parts by weight, the siloxane macromer of formula (II) is present at an amount of 5 to 20 parts by weight and the initiator is present at an amount of 0.1 to 1 parts by weight based on the total amount of the mixture. Furthermore, the hydrophilic monomer used in this embodiment is a combination of HEMA and NVP, wherein the HEMA is present at an amount of 1 to 20 parts by weight and the NVP is present at an amount of 40 to 55 parts by weight based on the total amount of the mixture.

In still another embodiment of the method of the present invention, the step of forming the mixture comprises mixing a siloxane macromer of formula (I) defined as above, a hydrophilic monomer, an initiator and a siloxane macromer of formula (II) defined as above to form the mixture. In the method of this embodiment, the siloxane macromer of formula (I) is present at an amount of 15 to 45 parts by weight, the hydrophilic monomer is present at an amount of 40 to 75 parts by weight, the siloxane macromer of formula (II) is present at an amount of 5 to 30 parts by weight and the initiator is present at an amount of 0.1 to 1 parts by weight based on the total amount of the mixture. Furthermore, the hydrophilic monomer used in this embodiment is a combination of HEMA and NVP, wherein the HEMA is present at an amount of 1 to 15 parts by weight and the NVP is present at an amount of 40 to 60 parts by weight based on the total amount of the mixture.

In addition, the mixture could further comprise but not limited to a dye and an UV-blocking agent or other materials suitable used in the prior contact lenses for providing specific functions.

After forming the mixture, the mixture is injected into a mold of contact lens and heating the mixture to form contact lenses.

The heating treatment is conducted at a temperature in the range between about 30° C. to about 150° C., the reaction time is in the range from about 1 hour to 12 hours. In an embodiment of the method of the present invention, the heating treatment is conducted at 30-70° C. for 0-2 hours, 70-100° C. for 2-4 hours and 100-150° C. for 4-12 hours.

After the heating treatment, the method of the present invention can further comprise a water-imparting treatment. In an embodiment of the method of the present invention, the water-imparting treatment comprises but not limited to the following steps.

Firstly, the contact lenses are soaked in alcohol solution, then soaked in water, and finally soaked in a buffer solution to be equilibria.

The water content of the contact lenses according to the present invention is in the range of about 25% to 55%, and preferably in the range of 35% to 55%.

Additionally, the oxygen permeability of the contact lenses according to the present invention is more than 80, and preferably more than 100.

The present invention will be explained in further detail with reference to the examples. However, the present invention is not limited to these examples.

1. Synthesis of a siloxane macromer

A. Synthesis of siloxane macromer (A)

(1) The reaction scheme siloxane macromer (A) is shown as follow:

##STR00011##

(2) Preparation of siloxane macromer (A)

4.44 g of isophorone diisocyanate, 0.0025 g of dibutyltin dilaurate as the catalyst, and 40 mL of methylene chloride were added to a flask, and the solution stirred under a stream of nitrogen. Then, 20 g of α-butyl-ω-[3-(2,2-(dihydroxymethyl)butoxy)propyl]polydimethylsiloxane was accurately weighed and added dropwise to the solution over about 1 hour. After the reaction at room temperature for 12 hours, another 0.0025 g of dibutyltin dilaurate and 7.2 g of polyethylene glycol monomethacrylate were accurately weighed and added dropwise to the solution over about 1 hour. After the reaction is conducted at room temperature for another 12 hours, the resulting reaction product was washed with a large amount of water, and then dehydrated and filtered to obtain the raw product. Then, the methylene chloride was evaporated to obtain a siloxane macromer (A).

(3) The properties of siloxane macromer (A)

B. Synthesis of siloxane macromer (B)

(1) The reaction scheme of siloxane macromer (B) is shown as follow:

##STR00012##

(2) The preparation of siloxane macromer (B)

8.88 g of isophorone diisocyanate, 0.0025 g of dibutyltin dilaurate as the catalyst, and 40 mL of methylene chloride were added to a flask, and the solution was stirred under a stream of nitrogen. Then, 20 g of α-butyl-ω-[3-(2,2-(dihydroxymethyl)butoxy)propyl]polydimethylsiloxane was accurately weighed and added dropwise to the solution over about 1 hour. After the reaction at room temperature for 12 hours, another 0.0025 g of dibutyltin dilaurate and 14.4 g of polyethylene glycol monomethacrylate were accurately weighed and added dropwise to the solution over about 1 hour. After the reaction at room temperature for another 12 hours, the resulting reaction product was washed with a large amount of water, and then dehydrated and filtered to obtain a raw product. Then, the methylene chloride was evaporated to obtain a siloxane macromer (B).

(3) The properties of siloxane macromer (B)

2. Preparation of contact lenses

(1) The preparation steps

A siloxane macromer and a hydrophilic monomer were mixed as the weight percentages shown in Table 1, and a dye and an UV-blocking agent were additionally added to make the contact lenses easily to be recognized and prevent UV light. The initiator was added into the mixture. The mixture was then injected into a mold of contact lens made of polypropylene (PP) and heated to initiate the radical polymerization thereof to obtain a heat-reaction silicone hydrogel contact lenses with high oxygen permeability.

TABLE 1
The recipe of contact lenses according to the present invention
Siloxane macromer (A) 15~60%
Siloxane macromer (B)  0~30%
NVP 30~75%
HEMA
EDGMA  0~10%
ADVN 0.1~1%  

(2) The preparation of the contact lenses of Example 1-Example 8

A siloxane macrome (A), a siloxane macrome (B), 2-hydroxyethyl methacrylate (HEMA) and N-vinylpyrrolidone (NVP), an azobisisoheptonitrile (ADVN) and an ethylene glycol dimethacrylate (EGDMA) were mixed at the amounts shown in Table 2 for Example 1-Example 8, respectively and stirred about 1 hour.

Then, the mixtures were injected into a mold of contact lens made of polypropylene (PP) and heated to initiate the radical polymerization thereof at 60° C. for 1 hour, at 80° C. for 2 hours and then, at 135° C. for 2 hours.

After the polymerization was completed, the mold was immersed in 80% alcohol solution for 1 hour and the resulting molded lens was taken out of the mold. The resulting lens was conducted a hydration treatment to obtain a contact lenses with excellent oxygen permeability. Finally, a sterilizing treatment on the lens was conducted. The steps and the conditions of hydration treatment and sterilizing treatment were as follow:

The steps of hydration treatment of the contact lens

The conditions of sterilizing treatment: 121° C. for 30 minutes.

TABLE 2
The composition of contact lenses of Example 1-Example 8
Example (wt %)
Item Composition Function 1 2 3 4 5 6 7 8
Ingredients Siloxane Siloxane 20.9 20.9 20.9 41.8 41.8 41.8 38.6 38.8
macromer macromer
(A)
Siloxane Siloxane 20.9 18.8 16.7 6.3 6.3 6.3 5.8 0
macromer macromer
(B)
NVP Hydrophilic 51.2 51.2 51.2 44.9 43.9 41.8 41.5 48.5
monomer
HEMA Hydrophilic 6.3 6.3 6.3 6.3 6.3 6.3 13.5 4.8
monomer
EDGMA Crosslinking 0 2.1 4.2 0 1 3.1 0 7.3
agent
ADVN Initiator 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7
Total 100 100 100 100 100 100 100 100
Total/Solvent Hexanol Solvent 25.1 25.1 25.1 25.1 25.1 25.1 9.7 32

(3) Physical property tests

The results of physical property tests of Comparative Example 1 (O2OPTiX, commercially available from Ciba), Comparative Example 2 (Pure Vision, commercially available from B&L) and Example 1-Example 8 of the present invention were shown as the following Table 3.

TABLE 3
The result of physical property tests
Comparative
Example Example
Item 1 2 3 4 5 6 7 8 1 2
Water 49.8 34.9 27.3 30.1 48.8 29.2 53.23 51.5 36 33
content(%)
Modulus 0.41 0.4 0.44 0.42 0.41 0.4 0.68 0.58 1 0.93
(Mpa)
Tension 12 15 22 14 89 37 103 60
(g)
Oxygen 118 81.8 89 150 138.6 124.3 100 101 75 84
permeability
(Dk)

As shown in Table 3, the contact lenses according to the present invention have more excellent oxygen permeability than comparative examples. Moreover the oxygen permeability of Example 1, Example 4, Example 5, Example 6, Example 7 and Example 8 are higher than 100, and the oxygen permeability of Example 4 is even up to 150. In addition, the water content of Example 1, Example 5, Example 7 and Example 8 are more than 45%, but the water content of Comparative Example 1 and Comparative Example 2 are only 36% and 33%, respectively.

According to the present invention, the contact lenses have more excellent oxygen permeability and water content than the conventional contact lenses.

While the invention has been described by way of example(s) and in terms of the preferred embodiment(s) it is to be understood that the invention is not limited thereto. On the contrary, it is intended to cover various modifications and similar arrangements and procedures, and the scope of the appended claims therefore should be accorded the broadest interpretation so as to encompass all such modifications and similar arrangements and procedures.

Jan, Fan-Dan

Patent Priority Assignee Title
Patent Priority Assignee Title
9086528, Mar 18 2013 BenQ Materials Corporation Material for contact lenses, method for manufacturing contact lenses and contact lenses obtained thereby
20020005933,
JP2000501853,
TW491951,
//
Executed onAssignorAssigneeConveyanceFrameReelDoc
Oct 11 2016JAN, FAN-DANBenQ Materials CorporationASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0404570765 pdf
Oct 19 2016BenQ Materials Corporation(assignment on the face of the patent)
Date Maintenance Fee Events
Jan 10 2022M1551: Payment of Maintenance Fee, 4th Year, Large Entity.


Date Maintenance Schedule
Oct 16 20214 years fee payment window open
Apr 16 20226 months grace period start (w surcharge)
Oct 16 2022patent expiry (for year 4)
Oct 16 20242 years to revive unintentionally abandoned end. (for year 4)
Oct 16 20258 years fee payment window open
Apr 16 20266 months grace period start (w surcharge)
Oct 16 2026patent expiry (for year 8)
Oct 16 20282 years to revive unintentionally abandoned end. (for year 8)
Oct 16 202912 years fee payment window open
Apr 16 20306 months grace period start (w surcharge)
Oct 16 2030patent expiry (for year 12)
Oct 16 20322 years to revive unintentionally abandoned end. (for year 12)